Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR

Aims Pleomorphic lobular carcinoma of the breast is a histological variant of infiltrating lobular carcinoma with a poor prognosis. The aim of this study is to investigate the immunohistochemical profile of this distinctive breast carcinoma in comparison with the classical type. The expression of cy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Histopathology 2000-02, Vol.36 (2), p.156-160
1. Verfasser: RADHI, J. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 160
container_issue 2
container_start_page 156
container_title Histopathology
container_volume 36
creator RADHI, J. M
description Aims Pleomorphic lobular carcinoma of the breast is a histological variant of infiltrating lobular carcinoma with a poor prognosis. The aim of this study is to investigate the immunohistochemical profile of this distinctive breast carcinoma in comparison with the classical type. The expression of cytokeratin, epithelial membrane antigen, gross cystic disease fluid protein‐15, chromogranin, oestrogen and progesterone receptors and p53 oncoprotein was investigated to examine whether the expression of these markers correlates with the aggressiveness of this variant. Methods and results Sections from 10 cases of pleomorphic lobular carcinomas were reviewed and examined for the expression of cytokeratin of high and low molecular weight, epithelial membrane antigen (EMA), gross cystic disease fluid protein‐15 (GCDFP‐15), chromogranin, oestrogen (ER) and progesterone receptors (PgR), and p53 oncoprotein. Immunohistochemical staining was performed on paraffin wax embedded sections. Ten cases of classical lobular carcinomas were used for comparison. A semiquantitative count of the percentage of positive tumour cells was recorded. Pleomorphic lobular carcinomas have most of the characteristic histological features of the classical type but have nuclear anaplasia and abundant granular cytoplasm. Clinically they exhibited poor prognosis and a high frequency of nodal metastases. All of the pleomorphic lobular carcinomas expressed low and high molecular weight keratin, EMA, and GCDFP‐15, eight cases expressed nuclear p53 at a range between 10% and 45%. All cases expressed chromogranin (3–5%). ER and PgR were weakly positive in two cases and negative in eight cases. Classical infiltrating lobular carcinomas were all positive for cytokeratin, EMA, ER and PgR and negative for GCDFP‐15. Only five cases of classical lobular carcinoma expressed p53 positivity with up to 5% nuclear staining while chromogranin showed less expression (1–2%). Conclusion Pleomorphic lobular carcinoma exhibits distinct cellular features with apocrine differentiation, higher expression of chromogranin and p53 protein and lower ER and PgR in comparison with classical lobular carcinomas. Determination of p53 overexpression and reduced or absent expression of ER and PgR may help predict the behaviour of this variant of lobular carcinoma.
doi_str_mv 10.1046/j.1365-2559.2000.00810.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70912585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70912585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4310-d4d468924bb54d6eb2c7262a853e36c0f4835ec7b9ab91c8a2c41037895d8223</originalsourceid><addsrcrecordid>eNqNkc1O3DAUha2qVZkOfYUqi6q7DP5PUnXTIgZGIFoBEkvLcZyJp04cbCJmnoGXxpmMaKVuuvKV7_nuvToHgATBBYKUn2wWiHCWYsaKBYYQLiDMY2_7BsxeG2_BDBJYpBDx7Ah8CGEDIcoIxu_BEYI8w5CjGXhete3QucaER6ca3RolbSI7aXfBhMTVSW-1a53vG6MS68rBSp8o6ZXpXCu_Jo1ZN9onett7HYJx3Z5hJM6oEtX4yK697Ey3_7Du6R_x2c2-9Wt9cwze1dIG_fHwzsHd8uzu9CK9-nm-Ov1-lSpKEEwrWlGeF5iWJaMV1yVWGeZY5oxowhWsaU6YVllZyLJAKpdYUQRJlhesyjEmc_BlGtt79zDo8ChaE5S2VnbaDUFksECYxWlzkE9C5V0IXtei96aVficQFGMOYiNGu8VotxhzEPscxDainw47hrLV1V_gZHwUfD4IZIiW19EjZcIfHY5XkPHWb5PsyVi9--_94mJ1G4uIpxMe49XbV1z634JnJGPi_vpcXC5_XNP7JROUvADex7Oi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70912585</pqid></control><display><type>article</type><title>Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>RADHI, J. M</creator><creatorcontrib>RADHI, J. M</creatorcontrib><description>Aims Pleomorphic lobular carcinoma of the breast is a histological variant of infiltrating lobular carcinoma with a poor prognosis. The aim of this study is to investigate the immunohistochemical profile of this distinctive breast carcinoma in comparison with the classical type. The expression of cytokeratin, epithelial membrane antigen, gross cystic disease fluid protein‐15, chromogranin, oestrogen and progesterone receptors and p53 oncoprotein was investigated to examine whether the expression of these markers correlates with the aggressiveness of this variant. Methods and results Sections from 10 cases of pleomorphic lobular carcinomas were reviewed and examined for the expression of cytokeratin of high and low molecular weight, epithelial membrane antigen (EMA), gross cystic disease fluid protein‐15 (GCDFP‐15), chromogranin, oestrogen (ER) and progesterone receptors (PgR), and p53 oncoprotein. Immunohistochemical staining was performed on paraffin wax embedded sections. Ten cases of classical lobular carcinomas were used for comparison. A semiquantitative count of the percentage of positive tumour cells was recorded. Pleomorphic lobular carcinomas have most of the characteristic histological features of the classical type but have nuclear anaplasia and abundant granular cytoplasm. Clinically they exhibited poor prognosis and a high frequency of nodal metastases. All of the pleomorphic lobular carcinomas expressed low and high molecular weight keratin, EMA, and GCDFP‐15, eight cases expressed nuclear p53 at a range between 10% and 45%. All cases expressed chromogranin (3–5%). ER and PgR were weakly positive in two cases and negative in eight cases. Classical infiltrating lobular carcinomas were all positive for cytokeratin, EMA, ER and PgR and negative for GCDFP‐15. Only five cases of classical lobular carcinoma expressed p53 positivity with up to 5% nuclear staining while chromogranin showed less expression (1–2%). Conclusion Pleomorphic lobular carcinoma exhibits distinct cellular features with apocrine differentiation, higher expression of chromogranin and p53 protein and lower ER and PgR in comparison with classical lobular carcinomas. Determination of p53 overexpression and reduced or absent expression of ER and PgR may help predict the behaviour of this variant of lobular carcinoma.</description><identifier>ISSN: 0309-0167</identifier><identifier>EISSN: 1365-2559</identifier><identifier>DOI: 10.1046/j.1365-2559.2000.00810.x</identifier><identifier>PMID: 10672061</identifier><language>eng</language><publisher>Oxford, U.K. and Cambridge, USA: Blackwell Publishing Ltd</publisher><subject>Aged ; Aged, 80 and over ; Apolipoproteins ; Apolipoproteins D ; Biological and medical sciences ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Carcinoma, Ductal, Breast - metabolism ; Carcinoma, Ductal, Breast - pathology ; Carcinoma, Lobular - metabolism ; Carcinoma, Lobular - pathology ; Carrier Proteins - analysis ; chromogranin receptors ; Chromogranins - analysis ; Female ; Glycoproteins ; Gynecology. Andrology. Obstetrics ; Humans ; Immunohistochemistry ; Keratins - analysis ; lobular carcinoma ; Mammary gland diseases ; Medical sciences ; Membrane Transport Proteins ; Middle Aged ; Mucin-1 - analysis ; p53 ; pleomorphic ; Receptors, Estrogen - analysis ; Receptors, Progesterone - analysis ; Tumor Suppressor Protein p53 - analysis ; Tumors</subject><ispartof>Histopathology, 2000-02, Vol.36 (2), p.156-160</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4310-d4d468924bb54d6eb2c7262a853e36c0f4835ec7b9ab91c8a2c41037895d8223</citedby><cites>FETCH-LOGICAL-c4310-d4d468924bb54d6eb2c7262a853e36c0f4835ec7b9ab91c8a2c41037895d8223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2559.2000.00810.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2559.2000.00810.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1270932$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10672061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RADHI, J. M</creatorcontrib><title>Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR</title><title>Histopathology</title><addtitle>Histopathology</addtitle><description>Aims Pleomorphic lobular carcinoma of the breast is a histological variant of infiltrating lobular carcinoma with a poor prognosis. The aim of this study is to investigate the immunohistochemical profile of this distinctive breast carcinoma in comparison with the classical type. The expression of cytokeratin, epithelial membrane antigen, gross cystic disease fluid protein‐15, chromogranin, oestrogen and progesterone receptors and p53 oncoprotein was investigated to examine whether the expression of these markers correlates with the aggressiveness of this variant. Methods and results Sections from 10 cases of pleomorphic lobular carcinomas were reviewed and examined for the expression of cytokeratin of high and low molecular weight, epithelial membrane antigen (EMA), gross cystic disease fluid protein‐15 (GCDFP‐15), chromogranin, oestrogen (ER) and progesterone receptors (PgR), and p53 oncoprotein. Immunohistochemical staining was performed on paraffin wax embedded sections. Ten cases of classical lobular carcinomas were used for comparison. A semiquantitative count of the percentage of positive tumour cells was recorded. Pleomorphic lobular carcinomas have most of the characteristic histological features of the classical type but have nuclear anaplasia and abundant granular cytoplasm. Clinically they exhibited poor prognosis and a high frequency of nodal metastases. All of the pleomorphic lobular carcinomas expressed low and high molecular weight keratin, EMA, and GCDFP‐15, eight cases expressed nuclear p53 at a range between 10% and 45%. All cases expressed chromogranin (3–5%). ER and PgR were weakly positive in two cases and negative in eight cases. Classical infiltrating lobular carcinomas were all positive for cytokeratin, EMA, ER and PgR and negative for GCDFP‐15. Only five cases of classical lobular carcinoma expressed p53 positivity with up to 5% nuclear staining while chromogranin showed less expression (1–2%). Conclusion Pleomorphic lobular carcinoma exhibits distinct cellular features with apocrine differentiation, higher expression of chromogranin and p53 protein and lower ER and PgR in comparison with classical lobular carcinomas. Determination of p53 overexpression and reduced or absent expression of ER and PgR may help predict the behaviour of this variant of lobular carcinoma.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Apolipoproteins</subject><subject>Apolipoproteins D</subject><subject>Biological and medical sciences</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Carcinoma, Ductal, Breast - metabolism</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Carcinoma, Lobular - metabolism</subject><subject>Carcinoma, Lobular - pathology</subject><subject>Carrier Proteins - analysis</subject><subject>chromogranin receptors</subject><subject>Chromogranins - analysis</subject><subject>Female</subject><subject>Glycoproteins</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Keratins - analysis</subject><subject>lobular carcinoma</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Membrane Transport Proteins</subject><subject>Middle Aged</subject><subject>Mucin-1 - analysis</subject><subject>p53</subject><subject>pleomorphic</subject><subject>Receptors, Estrogen - analysis</subject><subject>Receptors, Progesterone - analysis</subject><subject>Tumor Suppressor Protein p53 - analysis</subject><subject>Tumors</subject><issn>0309-0167</issn><issn>1365-2559</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1O3DAUha2qVZkOfYUqi6q7DP5PUnXTIgZGIFoBEkvLcZyJp04cbCJmnoGXxpmMaKVuuvKV7_nuvToHgATBBYKUn2wWiHCWYsaKBYYQLiDMY2_7BsxeG2_BDBJYpBDx7Ah8CGEDIcoIxu_BEYI8w5CjGXhete3QucaER6ca3RolbSI7aXfBhMTVSW-1a53vG6MS68rBSp8o6ZXpXCu_Jo1ZN9onett7HYJx3Z5hJM6oEtX4yK697Ey3_7Du6R_x2c2-9Wt9cwze1dIG_fHwzsHd8uzu9CK9-nm-Ov1-lSpKEEwrWlGeF5iWJaMV1yVWGeZY5oxowhWsaU6YVllZyLJAKpdYUQRJlhesyjEmc_BlGtt79zDo8ChaE5S2VnbaDUFksECYxWlzkE9C5V0IXtei96aVficQFGMOYiNGu8VotxhzEPscxDainw47hrLV1V_gZHwUfD4IZIiW19EjZcIfHY5XkPHWb5PsyVi9--_94mJ1G4uIpxMe49XbV1z634JnJGPi_vpcXC5_XNP7JROUvADex7Oi</recordid><startdate>200002</startdate><enddate>200002</enddate><creator>RADHI, J. M</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200002</creationdate><title>Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR</title><author>RADHI, J. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4310-d4d468924bb54d6eb2c7262a853e36c0f4835ec7b9ab91c8a2c41037895d8223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Apolipoproteins</topic><topic>Apolipoproteins D</topic><topic>Biological and medical sciences</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Carcinoma, Ductal, Breast - metabolism</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Carcinoma, Lobular - metabolism</topic><topic>Carcinoma, Lobular - pathology</topic><topic>Carrier Proteins - analysis</topic><topic>chromogranin receptors</topic><topic>Chromogranins - analysis</topic><topic>Female</topic><topic>Glycoproteins</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Keratins - analysis</topic><topic>lobular carcinoma</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Membrane Transport Proteins</topic><topic>Middle Aged</topic><topic>Mucin-1 - analysis</topic><topic>p53</topic><topic>pleomorphic</topic><topic>Receptors, Estrogen - analysis</topic><topic>Receptors, Progesterone - analysis</topic><topic>Tumor Suppressor Protein p53 - analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RADHI, J. M</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Histopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RADHI, J. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR</atitle><jtitle>Histopathology</jtitle><addtitle>Histopathology</addtitle><date>2000-02</date><risdate>2000</risdate><volume>36</volume><issue>2</issue><spage>156</spage><epage>160</epage><pages>156-160</pages><issn>0309-0167</issn><eissn>1365-2559</eissn><abstract>Aims Pleomorphic lobular carcinoma of the breast is a histological variant of infiltrating lobular carcinoma with a poor prognosis. The aim of this study is to investigate the immunohistochemical profile of this distinctive breast carcinoma in comparison with the classical type. The expression of cytokeratin, epithelial membrane antigen, gross cystic disease fluid protein‐15, chromogranin, oestrogen and progesterone receptors and p53 oncoprotein was investigated to examine whether the expression of these markers correlates with the aggressiveness of this variant. Methods and results Sections from 10 cases of pleomorphic lobular carcinomas were reviewed and examined for the expression of cytokeratin of high and low molecular weight, epithelial membrane antigen (EMA), gross cystic disease fluid protein‐15 (GCDFP‐15), chromogranin, oestrogen (ER) and progesterone receptors (PgR), and p53 oncoprotein. Immunohistochemical staining was performed on paraffin wax embedded sections. Ten cases of classical lobular carcinomas were used for comparison. A semiquantitative count of the percentage of positive tumour cells was recorded. Pleomorphic lobular carcinomas have most of the characteristic histological features of the classical type but have nuclear anaplasia and abundant granular cytoplasm. Clinically they exhibited poor prognosis and a high frequency of nodal metastases. All of the pleomorphic lobular carcinomas expressed low and high molecular weight keratin, EMA, and GCDFP‐15, eight cases expressed nuclear p53 at a range between 10% and 45%. All cases expressed chromogranin (3–5%). ER and PgR were weakly positive in two cases and negative in eight cases. Classical infiltrating lobular carcinomas were all positive for cytokeratin, EMA, ER and PgR and negative for GCDFP‐15. Only five cases of classical lobular carcinoma expressed p53 positivity with up to 5% nuclear staining while chromogranin showed less expression (1–2%). Conclusion Pleomorphic lobular carcinoma exhibits distinct cellular features with apocrine differentiation, higher expression of chromogranin and p53 protein and lower ER and PgR in comparison with classical lobular carcinomas. Determination of p53 overexpression and reduced or absent expression of ER and PgR may help predict the behaviour of this variant of lobular carcinoma.</abstract><cop>Oxford, U.K. and Cambridge, USA</cop><pub>Blackwell Publishing Ltd</pub><pmid>10672061</pmid><doi>10.1046/j.1365-2559.2000.00810.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0309-0167
ispartof Histopathology, 2000-02, Vol.36 (2), p.156-160
issn 0309-0167
1365-2559
language eng
recordid cdi_proquest_miscellaneous_70912585
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
Apolipoproteins
Apolipoproteins D
Biological and medical sciences
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Carcinoma, Ductal, Breast - metabolism
Carcinoma, Ductal, Breast - pathology
Carcinoma, Lobular - metabolism
Carcinoma, Lobular - pathology
Carrier Proteins - analysis
chromogranin receptors
Chromogranins - analysis
Female
Glycoproteins
Gynecology. Andrology. Obstetrics
Humans
Immunohistochemistry
Keratins - analysis
lobular carcinoma
Mammary gland diseases
Medical sciences
Membrane Transport Proteins
Middle Aged
Mucin-1 - analysis
p53
pleomorphic
Receptors, Estrogen - analysis
Receptors, Progesterone - analysis
Tumor Suppressor Protein p53 - analysis
Tumors
title Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A03%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunohistochemical%20analysis%20of%20pleomorphic%20lobular%20carcinoma:%20higher%20expression%20of%20p53%20and%20chromogranin%20and%20lower%20expression%20of%20ER%20and%20PgR&rft.jtitle=Histopathology&rft.au=RADHI,%20J.%20M&rft.date=2000-02&rft.volume=36&rft.issue=2&rft.spage=156&rft.epage=160&rft.pages=156-160&rft.issn=0309-0167&rft.eissn=1365-2559&rft_id=info:doi/10.1046/j.1365-2559.2000.00810.x&rft_dat=%3Cproquest_cross%3E70912585%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70912585&rft_id=info:pmid/10672061&rfr_iscdi=true